Aaron Ammerman

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Waters (United States)

Evotec (United States)

United States Food and Drug Administration

Janssen (United States)

Aaron Ammerman is an author at Merck KGaA, Darmstadt (Germany) specializing in assay validation, pharmaceutical analysis, and mass spectrometric analysis.

ORCID

Publications per year

2017–2024

Publications

New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study

Trina Mouchahoir, John E. Schiel, Rich Rogers et al. · Journal of the American Society for Mass Spectrometry · 2021 · 41 citations · Full text

Pharmacy, Biochemistry, Pharmaceutical Analysis +17

Expression, purification, and spectral tuning of RhoGC, a retinylidene/guanylyl cyclase fusion protein and optogenetics tool from the aquatic fungus Blastocladiella emersonii

Melissa M. Trieu, Erin L. Devine, Lindsey B. Lamarche et al. · Journal of Biological Chemistry · 2017 · 23 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory Study

Trina Mouchahoir, John E. Schiel, Rich Rogers et al. · Journal of the American Society for Mass Spectrometry · 2022 · 16 citations · Full text

Life Sciences, Pharmaceutical Analysis, Analytical Chemistry +16

Structural insights into vesicular monoamine storage and drug interactions

Jin Ye, Huaping Chen, Kaituo Wang et al. · Nature · 2024 · 16 citations · Full text

Medicine, Neuroscience, Pharmacology +16

1–4 of 4